KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Basic) (2016 - 2025)

Medpace Holdings (MEDP) has disclosed EPS (Basic) for 10 consecutive years, with $4.76 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 25.93% year-over-year to $4.76, compared with a TTM value of $15.64 through Dec 2025, up 19.75%, and an annual FY2025 reading of $15.64, up 19.75% over the prior year.
  • EPS (Basic) was $4.76 for Q4 2025 at Medpace Holdings, up from $3.95 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $4.76 in Q4 2025 and bottomed at $1.11 in Q2 2021.
  • Average EPS (Basic) over 5 years is $2.53, with a median of $2.33 recorded in 2023.
  • Peak annual rise in EPS (Basic) hit 63.24% in 2021, while the deepest fall reached 2.8% in 2021.
  • Year by year, EPS (Basic) stood at $1.39 in 2021, then soared by 56.12% to $2.17 in 2022, then grew by 17.51% to $2.55 in 2023, then skyrocketed by 48.24% to $3.78 in 2024, then grew by 25.93% to $4.76 in 2025.
  • Business Quant data shows EPS (Basic) for MEDP at $4.76 in Q4 2025, $3.95 in Q3 2025, and $3.16 in Q2 2025.